Prinocate 80 mg/8 mg 100 mg/ml - 10 mg/ml spot-on opl. Belgien - hollandsk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

prinocate 80 mg/8 mg 100 mg/ml - 10 mg/ml spot-on opl.

krka d.d. novo mesto d.d. - moxidectine 8 mg/0,8 ml; imidacloprid 80 mg/0,8 ml - spot-on oplossing - 100 mg/ml - 10 mg/ml - imidacloprid 100 mg/ml; moxidectine 10 mg/ml - moxidectin, combinations - kat

Imoxat Den Europæiske Union - hollandsk - EMA (European Medicines Agency)

imoxat

chanelle pharmaceuticals manufacturing ltd - imidacloprid, moxidectin - antiparasitic products, insecticides and repellents, macrocyclic lactones, milbemycins - cats; dogs; ferrets - for cats suffering from, or at risk from, mixed parasitic infections:• the treatment and prevention of flea infestation (ctenocephalides felis),• the treatment of ear mite infestation (otodectes cynotis),• the treatment of notoedric mange (notoedres cati),• the treatment of the lungworm eucoleus aerophilus (syn. capillaria aerophila) (adults),• the prevention of lungworm disease (l3/l4 larvae of aelurostrongylus abstrusus),• the treatment of the lungworm aelurostrongylus abstrusus (adults),• the treatment of the eye worm thelazia callipaeda (adults),• the prevention of heartworm disease (l3 and l4 larvae of dirofilaria immitis),• the treatment of infections with gastrointestinal nematodes (l4 larvae, immature adults and adults of toxocara cati and ancylostoma tubaeforme). het diergeneesmiddel kan worden gebruikt als onderdeel van een behandelingsstrategie voor vlooienallergie dermatitis (fad).  for ferrets suffering from, or at risk from, mixed parasitic infections:• the treatment and prevention of flea infestation (ctenocephalides felis),• the prevention of heartworm disease (l3 and l4 larvae of dirofilaria immitis).  for dogs suffering from, or at risk from, mixed parasitic infections:• the treatment and prevention of flea infestation (ctenocephalides felis),• the treatment of biting lice (trichodectes canis),• the treatment of ear mite infestation (otodectes cynotis), sarcoptic mange (caused by sarcoptes scabiei var. canis), demodicosis (caused by demodex canis),• the prevention of heartworm disease (l3 and l4 larvae of dirofilaria immitis),• the treatment of circulating microfilariae (dirofilaria immitis),• the treatment of cutaneous dirofilariosis (adult stages of dirofilaria repens)• the prevention of cutaneous dirofilariosis (l3 larvae of dirofilaria repens),• the reduction of circulating microfilariae (dirofilaria repens),• the prevention of angiostrongylosis (l4 larvae and immature adults of angiostrongylus vasorum),• the treatment of angiostrongylus vasorum and crenosoma vulpis,• the prevention of spirocercosis (spirocerca lupi),• the treatment of eucoleus (syn. capillaria) boehmi (adults),• the treatment of the eye worm thelazia callipaeda (adults),• the treatment of infections with gastrointestinal nematodes (l4 larvae, immature adults and adults of toxocara canis, ancylostoma caninum and uncinaria stenocephala, adults of toxascaris leonina and trichuris vulpis). het diergeneesmiddel kan worden gebruikt als onderdeel van een behandelingsstrategie voor vlooienallergie dermatitis (fad).

Prinocate 100 mg/25 mg 100 mg/ml - 25 mg/ml spot-on opl. Belgien - hollandsk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

prinocate 100 mg/25 mg 100 mg/ml - 25 mg/ml spot-on opl.

krka d.d. novo mesto d.d. - moxidectine 25 mg/1 ml; imidacloprid 100 mg/1 ml - spot-on oplossing - moxidectin, combinations

Prinocate 100 mg/25 mg 100 mg/ml - 25 mg/ml spot-on opl. Belgien - hollandsk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

prinocate 100 mg/25 mg 100 mg/ml - 25 mg/ml spot-on opl.

krka d.d. novo mesto d.d. - moxidectine 25 mg/1 ml; imidacloprid 100 mg/1 ml - spot-on oplossing - moxidectin, combinations

Prinocate 250 mg/62,5 mg 100 mg/ml - 25 mg/ml spot-on opl. Belgien - hollandsk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

prinocate 250 mg/62,5 mg 100 mg/ml - 25 mg/ml spot-on opl.

krka d.d. novo mesto d.d. - imidacloprid 250 mg/2,5 ml; moxidectine 62,5 mg/2,5 ml - spot-on oplossing - moxidectin, combinations

Prinocate 250 mg/62,5 mg 100 mg/ml - 25 mg/ml spot-on opl. Belgien - hollandsk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

prinocate 250 mg/62,5 mg 100 mg/ml - 25 mg/ml spot-on opl.

krka d.d. novo mesto d.d. - imidacloprid 250 mg/2,5 ml; moxidectine 62,5 mg/2,5 ml - spot-on oplossing - moxidectin, combinations

Prinocate 40 mg/10 mg 100 mg/ml - 25 mg/ml spot-on opl. Belgien - hollandsk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

prinocate 40 mg/10 mg 100 mg/ml - 25 mg/ml spot-on opl.

krka d.d. novo mesto d.d. - moxidectine 10 mg/0,4 ml; imidacloprid 40 mg/0,4 ml - spot-on oplossing - moxidectin, combinations

Prinocate 40 mg/10 mg 100 mg/ml - 25 mg/ml spot-on opl. Belgien - hollandsk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

prinocate 40 mg/10 mg 100 mg/ml - 25 mg/ml spot-on opl.

krka d.d. novo mesto d.d. - moxidectine 10 mg/0,4 ml; imidacloprid 40 mg/0,4 ml - spot-on oplossing - moxidectin, combinations

Prinocate 40 mg/4 mg 100 mg/ml - 10 mg/ml spot-on opl. Belgien - hollandsk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

prinocate 40 mg/4 mg 100 mg/ml - 10 mg/ml spot-on opl.

krka d.d. novo mesto d.d. - moxidectine 4 mg/0,4 ml; imidacloprid 40 mg/0,4 ml - spot-on oplossing - moxidectin, combinations

Prinocate 40 mg/4 mg 100 mg/ml - 10 mg/ml spot-on opl. Belgien - hollandsk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

prinocate 40 mg/4 mg 100 mg/ml - 10 mg/ml spot-on opl.

krka d.d. novo mesto d.d. - moxidectine 4 mg/0,4 ml; imidacloprid 40 mg/0,4 ml - spot-on oplossing - moxidectin, combinations